fbpx

Notable Publications from OmegaQuant Researchers

For a complete list of Dr. Harris’ publications, please click here.

 

  • Harris WS and von Schacky C. The Omega-3 Index: A New Risk Factor for Death from CHD? Preventive Medicine 2004;39:212-220.
  • Harris WS, Sands SA, Windsor SL, Ali HA, Stevens TL, Magalski A, Porter CB, Borkon AM. Omega-3 Fatty Acid Levels in Transplanted Human Hearts: Effect of Supplementation and Comparison with Erythrocytes. Circulation 2004;110;1645-49.
  • Shearer GC, Pottala JV, Harris WS, et al. Red Blood Cell Fatty Acid Patterns and Acute Coronary Syndrome. PLoS ONE 2009;4(5): e5444.
  • Carney RM, Freeland KE, Harris WS, et al. Omega-3 augmentation of sertraline in the treatment of depression in patients with coronary heart disease: a randomized controlled trial. JAMA 2009; 302:1651-1657.
  • Farzaneh-Far R, Blackburn EH, Harris WS, et al. Association of marine omega-3 fatty acid levels with telomeric aging in patients with coronary heart disease. JAMA 2010;303:250-257.
  • Pottala JV, Whooley MA, Harris WS, et al. Blood EPA and DHA Independently Predict All-Cause Mortality in Patients with Stable Coronary Heart Disease. The Heart and Soul Study. Circulation: Qual Outcomes 2010;3:406-412.
  • Tan ZS, Harris WS, Beiser AS, et al. Red Blood Cell Omega-3 Fatty Acid Levels and Markers of Accelerated Brain Aging. Neurology 2012;78:658-664.
  • Harris WS, Pottala JV, Lacey SM, et al.  Clinical correlates and heritability of erythrocyte eicosapentaenoic and docosahexaenoic acid content in the Framingham Heart Study. Atherosclerosis 2012;225:425-31.
  • Harris WS, Pottala JV, Varvel SA, et al. Erythrocyte Omega-3 Fatty Acids Increase and Linoleic Acid Decreases with Age: Observations in 160,000 Patients. Prostaglandins Leukot Essent Fatty Acids. 2013;88:257-63.
  • Harris WS, Kennedy KF, O’Keefe JH, et al. Red blood cell fatty acid levels improve GRACE score prediction of 2-yr mortality in patients with myocardial infarction. Intl J Cardiology 2013;168:53-59.
  • Harris WS, Varvel SA, Pottala JV, Warnick GR, McConnell JP. The Comparative Effects Of An Acute Dose Of Fish Oil On Omega-3 Fatty Acid Levels in Red Blood Cells Versus Plasma: Implications for Clinical Utility. J Clin Lipidol 2013;7:433-440.
  • Persons JE, Robinson, JG, Ammann EM, Coryell WH, Espeland MA, Harris WS, Manson JE, Fiedorowicz JG. Omega-3 Fatty Acid Biomarkers and Subsequent Depressive Symptoms. Intl J Geriatric Psychiatry 2014;29;747-757.
  • Flock MR, Skulas-Ray AC, Harris WS, Etherton TD, Fleming JA, Kris-Etherton PM. Determinants of Erythrocyte Omega-3 Fatty Acid Content in Response to Fish Oil Supplementation: A Dose-Response Randomized Controlled Trial. J Am Heart Assoc.2013;2:e000513.
  • Harris WS, Schmitt TL. Unexpected Similarity in Red Blood Cell Docosahexaenoic Acid and Arachidonic Acid Levels Between Bottlenose Dolphins and Humans. PLEFA 2014;90:55-9.
  • Pottala JV, Yaffe K, Robinson JG, Espeland MA, Wallace RB, Harris WS. Higher RBC EPA+DHA corresponds with larger total brain and hippocampal volumes: WHIMS-MRI study. Neurology 2014;82:435-42.
  • Gurzell EA, Weisinger J, Morkam C, Hemmrich S, Harris WS, Fenton JI. Is the Erythrocyte Membrane Fatty Acid Composition a Valid Index of Intestinal Membrane Phospholipid Fatty Acid Composition? PLEFA 2014;91:87-96.
  • Dretsch MN, Johnston D, Bradley RS, Macrae H, Deuster PA, Harris WS. Effects of omega-3 Fatty Acid supplementation on neurocognitive functioning and mood in deployed u.s. Soldiers: a pilot study. Mil Med. 2014;179:396-403.
  • Nosova EV, Chong KC, Alley HF, Harris WS, Boscardin WJ, Conte MS, Owens CD, Grenon SM. Clinical Correlates of Red Blood Cell Omega-3 Fatty Acid Content in Male Veterans with Peripheral Arterial Disease. J Vasc Surg 2014;60:1325-31.
  • Flock MR, Skulas-Ray AC, Harris WS, Gaugler TL, Fleming JA, Kris-Etherton PM. Effects of supplemental long-chain omega-3 fatty acids and erythrocyte membrane fatty acid content on circulating inflammatory markers in a randomized controlled trial of healthy adults. PLEFA 2014;91:161-8.
  • Harris WS, Shearer GC. Omega-6 Fatty Acids and Cardiovascular Disease: Friends, not Foes? Circulation 2014: 130:1562-4.
  • Yakes Jimenez E, Mangani C, Ashorn P, Harris WS, Maleta K, Dewey KG. Breast milk from women living near Lake Malawi is high in docosahexaenoic acid and arachidonic acid. PLEFA 2014;95:71-78.
  • Tintle NL, Pottala JV, Lacey S, Ramachandran V, Westra J, Rogers A, Clark J, Olthoff B, Larson MK, Harris WS, Shearer GC. A genome-wide association study of saturated, mono- and polyunsaturated red blood cell fatty acids in the Framingham Heart Offspring Study. PLEFA 2014;94:65-72.
  • Kaess BM, Harris WS, Lacey S, Larson MG, Hamburg NM, Vita JA, Robins SJ, Benjamin EJ, Mitchell GF, Vasan RS. The relation of red blood cell fatty acids with vascular stiffness, cardiac structure and left ventricular function: The Framingham Heart Study. Vascular Medicine 2014;20:5-13.
  • Sarter B, Kelsey KS, Schwartz TA, Harris WS. Blood docosahexaenoic acid and eicosapentaenoic acid in vegans: Associations with age and gender and effects of an algal-derived omega-3 fatty acid supplement. Clin Nutr 2015;34:212-218.
  • Fontes JD, Rahman F, Lacey S, Larson MG, Vasan RS, Benjamin EJ, Harris WS, Robins SJ. Red Blood Cell Fatty Acids and Biomarkers of Inflammation: A Cross-sectional Study in a Community-based Cohort. Atherosclerosis 2015;240:431-6.
  • Baack ML, Puumala SE, Messier SE, Pritchett D, Harris WS.  What is the Relationship between Gestational Age and Docosahexaenoic Acid (DHA) and Arachidonic Acid (ARA) Levels? PLEFA. 2015;100:5-11

For a complete list of Dr. Jackson’s publications, please click here.

 

  • Allaire J, Harris WS, Vors C, Charest A, Marin J, Jackson KH, Tchernof A, Couture P, Lamarche B. Supplementation with high-dose docosahexaenoic acid increases the Omega-3 Index more then high-dose eicosapentaenoic acid. Prostaglandins Leukot Essent Fatty Acids. 2017; 120:8-14.
  • Jackson KH*, Juber BA*, Johnson KB, Harris WS, Baack ML. Breast milk DHA levels may increase after informing women: a community-based cohort study from South Dakota USA. Int Breastfeed J. 2017; 12:7.
  • Rudolph MC, Young BE, Jackson KH, Krebs NF, Harris WS, MacLean PS. Human Milk Fatty Acid Composition: Comparison of Novel Dried Milk Spot Versus Standard Liquid Extraction Methods. J Mammary Glad Biol Neoplasia. 2016; 11:1.
  • Harris Jackson K and Harris WS. Should there be a target level of DHA in breast milk? Current Opinion in Clinical Nutrition and Metabolic Care. 2016;19(2):92-96.
  • Harris Jackson K, Polreis J, Sanborn L, Chaima D, Harris WS. Analysis of breast milk fatty acid composition using dried milk samples. International Breastfeeding Journal. 2016;11:1.
  • Cardel M, Lemas DJ, Harris Jackson K, Friedman JE, Fernandez JR. Polyunsaturated fatty acid consumption: associations with total and visceral adiposity and lean mass in a racially diverse sample of children. J Nutr, 2015; 145(9): 2146-52.
  • Backes JM, Ruisinger JF, Harris KA, Gibson CA, Harris WS, Moriarty PM. Evaluating the effects of prescription fish oil, supplemental fish oil and a krill oil blend on serum lipids/lipoproteins and the omega-3 index: a pilot study. J Glycomics & Lipidomics 2014; 4(4).
  • Harris KA, Fleming JA, Kris-Etherton PM. Challenges in estimating omega-3 fatty acid content of seafood from nutrient databases: a salmon case study. Journal of Food and Composition Analysis. 2011; 24(8): 1168-1173.
  • Harris WS, Kris-Etherton PM, Harris KA. Intakes of long-chain omega-3 fatty acid associated with reduced risk for death from coronary heart disease in healthy adults. Curr Atheroscler Rep. 2008 Dec; 10(6):503-9.
  • Larson MK, Ashmore JH, Harris KA, Vogelaar JL, Pottala JV, Sprehe M, Harris WS. Effects of omega-3 acid ethyl esters and aspirin, alone and in combination, on platelet function in healthy subjects. Thromb Haemost. 2008 Oct;100(4):634-41.

These statements have not been evaluated by the Food and Drug Administration. This test is not intended to diagnose, treat, cure, prevent or mitigate any disease. This site does not offer medical advice, and nothing contained herein is intended to establish a doctor/patient relationship. OmegaQuant, LLC is regulated under the Clinical Laboratory improvement Amendments of 1988 (CLIA) and is qualified to perform high complexity clinical testing. The performance characteristics of this test were determined by OmegaQuant, LLC. It has not been cleared or approved by the U.S. Food and Drug Administration.